+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 10Years - 18Years
All Genders
ID07581457

Testing Two Tranexamic Acid Treatments Versus Placebo to Reduce Bleeding in Children 10 to 18 Years Having Surgery for Idiopathic Scoliosis

Led by Poznan University of Medical Sciences · Updated on 2026-07-01

90

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate whether tranexamic acid TXA, a medication used to reduce bleeding, is effective and safe in children aged 10 to 18 years undergoing surgery for idiopathic scoliosis. This surgery often involves significant blood loss and may require blood transfusions. The study compares two different intravenous TXA dosing strategies against a placebo to find the best approach for reducing blood loss and transfusion needs. Participants will be randomly assigned to one of three groups one group receives TXA as a 15 mgkg intravenous bolus followed by a continuous infusion during surgery another group receives two intravenous bolus doses of TXA at 10 mgkg each and the third group receives a placebo saline in the same volume and timing as the TXA groups. All patients will have standardized anesthesia, regional analgesia, and intraoperative neuromonitoring during the surgery. The maximum total TXA dose is limited to 2 grams. Participants will be followed for 30 days after surgery to monitor blood loss, transfusion volume, and laboratory measures such as hemoglobin and clotting factors. Safety will be assessed by tracking side effects including seizures and blood clots. Researchers will measure total blood loss within 24 hours after surgery as the primary outcome. The study includes detailed blood tests immediately after surgery and at 24 hours, with careful monitoring of patient health during the follow-up period.

CONDITIONS

Brief Title

Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery

Research Team

M

Malgorzata Reysner, MD PhD

P

Piotr Janusz, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here